GlobeNewswire

Dante Labs commits to ending Rare Disease Odysseys globally through Stripe2be: a patient-centric whole genome based solution tailored for rare disease patients

Share
  • Stripe2be uses an unbiased approach to Whole Genome Sequencing (WGS) for rare diseases: combining the information submitted from both personal patient records and statements, and using the Dante Labs proprietary WGS test and Immensa CE-IVD, ISO13485 Software.
  • Dante Labs provides affordable WGS based solutions to tens of thousands of rare disease patients worldwide, from the Marshall Islands to Brazil, from the UK to Australia
  • Dante Labs works and welcomes collaborations with rare disease advocacy groups
  • 8,000 rare and ultra-rare diseases affect 400 million people in the world. 75% of these patients are children; 30% of whom die before the age of 5-years

CAMBRIDGE, England, July 08, 2021 (GLOBE NEWSWIRE) -- Dante Labs, a leading genomics and diagnostics company, today announced the launch of Stripe2be, a platform and business unit fully dedicated to rare disease patients, offering personalized, AI-driven reports based on Whole Genome Sequencing and leveraging Dante Labs’ CE-IVD, ISO13485 certified Immensa Genomic Interpretation Software.

“I am excited to be part of the new Stripe2be team, where we provide people from all over the world with access to 100% of their own personal genetic data. Our WGS reports provide invaluable insight into - and the potential to improve - personal health; something that is especially important for those of us with a rare disease,” said Torie Robinson, Dante Labs Public Affairs & Patient Advocacy Manager for Stripe2be.

“Rare diseases affect a lot of people,” says Dante Labs CEO Andrea Riposati. “Too many rare disease patients live in countries with no access to genomics. Stripe2be is for rare disease patients in every country to access whole genome based interpretation and analysis tailored for rare diseases.”

About Rare Diseases
80% of rare diseases are genetic or have a genetic component. Understanding the genomics of rare diseases can help us understand the causes of undiagnosed disorders and help families avoid years of hospital visits and unnecessary testing.

On average, the long search for a rare disease diagnosis (the “Diagnostic Odyssey”):

  • Takes 5-6 years;
  • Involves 8 different physicians, and;
  • Involves multiple misdiagnoses

A superior approach dedicated to rare disease patients
The traditional approach to genomics and rare disease diagnoses is biased and restricts the use of genetic testing, often leading to patients’ unnecessarily going through countless doctor’s visits and partial genetic tests prior to diagnosis.

Dante Labs uses an unbiased, data rich, patient centric approach formed of three pillars:

  • Sequencing: Dante Labs sequences the patient’s entire genome multiple times; performing additional, enriching analyses of parts of the genome specific to rare diseases;
  • Patient Information: patients are encouraged to provide as much information on their medical background as possible. This includes information from both their medical records and personal descriptions of their symptoms, and;
  • Personalized Reports: Dante Labs’ CE-IVD, ISO13485 certified Immensa Genomic Interpretation Software provides a combined analysis of genomic, medical, and patient data to generate highly personalized rare disease reports for each person.

About Stripe2be.
Stripe2be is a Dante Labs Global Whole Genome Sequencing Platform dedicated to Rare Disease Genomics. Our commitment is to end the Diagnostic Odyssey faced by rare disease patients from around the world by providing advanced Genomic solutions; from advanced reporting to molecular diagnosis. Immenso, Dante Labs’ proprietary Whole Genome Sequencing Test, is the gold-standard in genomics applications. Through machine learning and a continuous feedback loop between our database and the clinical lab, our Genomic Interpretation Software offers an insightful, precise and fast analysis of complex genomic data. 
Website: https://stripe2be.com

About Dante Labs

Dante Labs is a global genomic data company building and commercialising a new class of transformative health and longevity applications based on whole genome sequencing and AI. Our assets include one of the largest private genome databases with research consent, a proprietary software platform designed to unleash the power of genomic data at scale and proprietary processes which enable an industrial approach to genomic sequencing.

Headquartered in Cambridge, United Kingdom, with a research laboratory in Wolverhampton, Dante Labs supported the UK Government’s urgent requirement to scale-up a high-capacity, highly automated testing solution for Covid-19, including infected patients as well as those with antibodies. Dante Labs was able to deliver by leveraging existing technology that had been developed for whole genome sequencing.

Website: www.dantelabs.com
Giorgio Lodi, media@dantelabs.com. +39 0862 191 0671

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/edaa3fae-8abb-4b55-a9d0-1202d9067fd0

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire

GlobeNewswire
GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://globenewswire.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire

Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire

FLSmidth to acquire thyssenkrupp’s Mining business – creating a global industry leader in mining technology29.7.2021 12:39:04 CEST | Press release

Company Announcement No. 7 2021 FLSmidth and thyssenkrupp Industrial Solutions AG (a fully owned subsidiary of thyssenkrupp AG, "thyssenkrupp") have reached an agreement that FLSmidth will acquire thyssenkrupp’s Mining business1 (TK Mining) for a total consideration (enterprise value) of EUR 325 million, corresponding to approximately DKK 2.4 billion. Closing of the transaction is expected in H2 2022 and is subject to customary approvals from relevant authorities. TK Mining is a leading full-line supplier of solutions for mining systems, material handling, mineral processing and services, which is highly complementary to FLSmidth’s offering. TK Mining has an asset light business model and is present in 24 countries with engineering and global service centres, and has close to 3,400 employees. In 20202, revenue was EUR 780 million (approximately DKK 5.8 billion) with around one-third deriving from services. The business delivered a high single-digit negative EBIT margin and is expected

Millicom to repurchase own shares29.7.2021 12:02:00 CEST | Press release

Millicom to repurchase own shares Luxembourg, July 29, 2021 – On May 4, 2021, the Annual General Meeting of Shareholders (“AGM”) of Millicom resolved to authorize (the “Authorization”) the Board of Directors of Millicom (the “Board”) to adopt a share repurchase plan. Based on the Authorization, the Board has decided to initiate a repurchase program comprising not more than 5,000,000 Swedish Depository Receipts representing the Company’s ordinary shares (“SDRs”). The purposes of the share repurchase plan may include: reduction of Millicom's share capital; meeting obligations for Board remuneration; and/or meeting obligations under Millicom’s share-based incentive plans or other compensation programs. The repurchase program will be implemented in accordance with the Authorization, the Nasdaq Nordic Main Market Rulebook for Issuers of Shares (“Nasdaq Rulebook”), and applicable law including the Luxembourg law of 10 August 1915 on commercial companies, as amended, and the EU Market Abuse R

Fobi Wallet Pass For Ticketing And Global Fan Engagement Powers bdG Sports “Baha Mar Hoops” Tournament Featuring 19 NCAA Men’s And Women’s Basketball Teams, Including US Thanksgiving Nationally Televised Events29.7.2021 12:00:00 CEST | Press release

After multiple event successes with bdG Sports, Fobi is now adding ticketing and admissions capabilities to live and digital fan engagement to deliver a comprehensive solution for the “largest early season event in all of college basketball” at Baha Mar Hoops in The Bahamas VANCOUVER, British Columbia., July 29, 2021 (GLOBE NEWSWIRE) -- Fobi AI Inc. (formerly Loop Insights Inc.) (TSXV: FOBI) (OTCQB: FOBIF) (the "Company" or "Fobi"), is pleased to announce it will once again be supporting bdG Sports for college basketball’s largest early season event. The invite-only global event at Baha Mar Convention Center in Nassau, The Bahamas will take place from November 22-27, 2021 and will use Fobi’s Wallet Pass platform for ticketing, admission, and fan engagement both live and at home. Fobi will earn significant revenue from this event through the event license, ticket fees and fan activations both live and at home, including nationally televised and digital audiences across the United States

Building momentum and delivering results29.7.2021 12:00:00 CEST | Press release

Building momentum and delivering results Luxembourg, July29, 2021– Millicom is pleased to announce its second quarter 2021 results. Please find below links to the Q2 2021 Earnings Release and H1 2021 Interim Condensed Consolidated Financial Statements. Millicom Chief Executive Officer Mauricio Ramos commented: "We had an outstanding Q2. We built on our robust Q1 performance and delivered double-digit growth in both service revenue and EBITDA. In Colombia, we now have the best mobile network, and we capitalized on this in Q2 by leading the market in portability and by adding a record number of new postpaid customers. Our rapid customer and revenue growth is a direct result of our unwavering commitment to delivering the best customer experience, including network quality and reliability. With that in mind, and considering our healthy cash flow generation, we have accelerated investments that we expect will help us drive faster growth in all our businesses going forward. In light of our s

Summary of AB Klaipedos nafta webinar29.7.2021 11:30:00 CEST | Press release

On the 29th July 2021, AB Klaipedos nafta (KN) held an investor conference webinar where KN Chief Executive Officer Darius Šilenskis and acting Chief Financial Officer Indrė Kisielienė commented Company’s financial results for the six months of 2021. Webinar recording is available online at: https://youtu.be/BmHfUpOVmEM The presentation demonstrated during the webinar is attached to this announcement. Indrė Kisielienė, Acting Chief Financial Officer, +370 686 16276 Attachment KN_activity results for_2021_Q2

Correction: AB Klaipėdos nafta financial information reporting dates in 202129.7.2021 10:15:00 CEST | Press release

Correction: AB Klaipedos nafta interim financial information for the 6 months of 2021 has been released on 29 July 2021. AB Klaipėdos nafta (further – KN) informs that it plans to release financial information in 2021 according to the following schedule: DateReporting informationWithin first 5 working days of every month of 2021KN preliminary revenues for the previous month29 January 2021Interim financial information for the year 20207 April 2021Audited financial statements for the year 202030 April 2021Interim financial information for the 1st quarter of 20218 June 2021Social responsibility report for the year 202029 July 2021Interim financial information for the 6 months of 202129 October 2021Interim financial information for the 3 quarters of 2021 On 30 April 2021, the Company plans to convene an Ordinary General Meeting of Shareholders. Indrė Kisielienė, Acting Chief Financial Officer, +370 686 16276.

Hexagon Digital Wave signs new equipment and service agreement with Linde29.7.2021 09:00:00 CEST | Press release

Hexagon Digital Wave, a business of Hexagon Composites has signed an agreement with Linde, a leading industrial gas and engineering company. The agreement covers the supply and service of Ultrasonic Examination (UE) testing equipment. The estimated total value of the agreement is USD 2 million (approx. NOK 17 million) and designates Hexagon Digital Wave as a long-term partner. Driving energy transformation “We are excited to extend our relationship with the great team at Linde”, says Keith Fountain, UE international Sales Manager Hexagon Digital Wave. “Over the past 14 years we have provided our equipment to one of the market leaders in the industrial gas environment and helped to improve the safety of their cylinders.” About the market The non-destructive UE test and process enables the recertification of the cylinders without removing the internal product which improves the safety and allows a number of ESG requirements to be accomplished. Positive environmental impacts are accomplis